- Home
- DYAI vs CLGN Comparison
DYAI vs CLGN Comparison
Compare DYAI & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | CLGN |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2M | 33.8M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYAI | CLGN |
|---|---|---|
| Price | $0.95 | $2.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 529.9K | 18.2K |
| Earning Date | 11-12-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,342,195.00 | $2,475,000.00 |
| Revenue This Year | $12.52 | $1,617.28 |
| Revenue Next Year | $92.04 | $83.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 280.77 |
| 52 Week Low | $0.71 | $1.31 |
| 52 Week High | $2.20 | $4.98 |
Technical Indicators
Market Signals| Indicator | DYAI | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 40.13 |
| Support Level | $0.85 | $1.92 |
| Resistance Level | $1.03 | $2.10 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 48.28 | 24.67 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.